Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9d0c82c6254d5b4bec8c96e45c9db7b |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 |
filingDate |
2007-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0303e3bae4b25f022efa96a6e22b1eaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4297119ae6733f9b3077132dd2ec2b84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65588f57bf4575de2b4df92bac6464c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc3d9b37eae163bba3704b53ca5cc59a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c59753cf37b0f6055998c7b2fd1a9b47 |
publicationDate |
2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008266220-A |
titleOfInvention |
Liver fibrosis inhibitor |
abstract |
PROBLEM TO BE SOLVED: To provide a safe hepatic fibrosis inhibitor without carcinogenic risk. The liver fibrosis inhibitor of the present invention comprises vascular endothelial precursor cells as an active ingredient. [Selection] Figure 1 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8951795-B2 |
priorityDate |
2007-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |